Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31trueNo description of principal activitytrue2024-04-012true2false 04727849 2024-04-01 2025-03-31 04727849 2023-04-01 2024-03-31 04727849 2025-03-31 04727849 2024-03-31 04727849 c:Director1 2024-04-01 2025-03-31 04727849 d:CurrentFinancialInstruments 2025-03-31 04727849 d:CurrentFinancialInstruments 2024-03-31 04727849 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 04727849 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 04727849 d:ShareCapital 2025-03-31 04727849 d:ShareCapital 2024-03-31 04727849 d:RetainedEarningsAccumulatedLosses 2025-03-31 04727849 d:RetainedEarningsAccumulatedLosses 2024-03-31 04727849 c:EntityHasNeverTraded 2024-04-01 2025-03-31 04727849 c:FRS102 2024-04-01 2025-03-31 04727849 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 04727849 c:FullAccounts 2024-04-01 2025-03-31 04727849 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04727849 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 04727849










W2 SURGERY SERVICES LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
W2 SURGERY SERVICES LIMITED
REGISTERED NUMBER:04727849

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
42,466
42,466

Creditors: amounts falling due within one year
 5 
(10,886)
(10,886)

  

Net assets
  
31,580
31,580


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
31,480
31,480

  
31,580
31,580


For the year ended 31 March 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




S S Golar
Director

Date: 4 December 2025

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
W2 SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

W2 Surgery Services Limited is a private company, limited by shares, incorporated in England within the United Kingdom. The address of the principal place of business is 6th Floor, 2 London Wall Place, London, EC2Y 5AU.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £1.

 
2.2

Going concern

The financial statements have been prepared on a going concern basis. As at the date of this report,
the directors conclude that there is no material uncertainty and that they can continue to adopt the
going concern basis in preparing the annual report and accounts.

 
2.3

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.5

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Page 2

 
W2 SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)


2.5
Financial instruments (continued)

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due within the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 3

 
W2 SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Debtors

2025
2024
£
£


Trade debtors
32,129
32,129

Other debtors
10,337
10,337

42,466
42,466



5.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank overdrafts
5
5

Amounts owed to group undertakings
8,332
8,332

Other creditors
2,549
2,549

10,886
10,886


Bank overdrafts of £5 (2024 - £5) are secured on the assets of the Company.


6.


Related party transactions

The Company has taken advantage of the exemption available in Financial Reporting Standard 102 Section 33 whereby it has not disclosed transactions with the ultimate parent company or any wholly owned subsidiary undertaking of the group.


7.


Ultimate parent company

The ultimate parent company is Golar Holdings Limited, a company incorporated in England and Wales.

Page 4